`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`AQUESTIVE THERAPEUTICS, INC.
`
`Petitioner
`
`V.
`
`HALE BIOPHARMA VENTURES, LLC
`
`Patent Owner
`
`Case: IPR2019—00450
`
`US. Patent No. 9,763,876
`
`POWER OF ATTORNEY UNDER 37 C.F.R. § 42.10(B)
`
`
`
`In accordance with 37 CPR. § 42.10(b), Petitioner, Aquestive Therapeutics,
`
`Inc. hereby appoints:
`
`Lead counsel
`
`First Back-up Counsel
`
`Daniel A. Scola, Jr.
`Reg. No. 29,855
`Hoffmann & Baron, LLP
`dscola@hbiplaw.com
`(973) 331-1700
`
`Michael I. Chakansky
`Reg. No. 31,600
`Hoffmann & Baron, LLP
`micdocket@hbiplaw.com
`(973) 331-1700
`
`Additional Back-up Counsel
`
`Additional Back-up Counsel
`
`James F. Harrington
`Reg. No. 44,741
`Hoffmann & Baron, LLP
`jharrington@hbiplaw.com
`(516) 822—3550
`
`Matthew J. Solow
`Reg. No. 56,878
`Hoffmann & Baron, LLP
`msolow@hbiplaw.com
`(973) 331-1700
`
`and all other practitioners associated with Customer Number 23869 as attorney(s)
`
`or agents(s) to represent Aquestive Therapeutics, Inc. in the review proceeding for
`
`the patent identified above, before the Patent Trial and Appeal Board in the United
`
`States Patent and Trademark Office, and to transact all business connected
`
`therewith.
`
`I have authority to sign this document on behalf of Petitioner Aquestive
`
`
`he apeutics, Inc
`
`
` Mark Sc
`e1
`Aquestive Therapeutics, Inc.
`
`Title: Chief Innovation & Technology Officer
`
`Date
`
`